The latest closing stock price for Fate Therapeutics as of May 30, 2025 is 1.21.
An investor who bought $1,000 worth of Fate Therapeutics stock at the IPO in 2013 would have $-817 today, roughly -1 times their original investment - a -13.21% compound annual growth rate over 12 years.
The all-time high Fate Therapeutics stock closing price was 117.40 on January 14, 2021.
The Fate Therapeutics 52-week high stock price is 5.92, which is 389.3% above the current share price.
The Fate Therapeutics 52-week low stock price is 0.66, which is 45.5% below the current share price.
The average Fate Therapeutics stock price for the last 52 weeks is 2.41.
An investor who bought $1,000 worth of Fate Therapeutics stock at the IPO in 2013 would have $-817 today, roughly -1 times their original investment - a -13.21% compound annual growth rate over 12 years.
The all-time high Fate Therapeutics stock closing price was 117.40 on January 14, 2021.
The Fate Therapeutics 52-week high stock price is 5.92, which is 389.3% above the current share price.
The Fate Therapeutics 52-week low stock price is 0.66, which is 45.5% below the current share price.
The average Fate Therapeutics stock price for the last 52 weeks is 2.41.